ES2183486T3 - Formulaciones de fsh y de variantes de fsh que comprenden alcohol bencilico como agente preservativo. - Google Patents
Formulaciones de fsh y de variantes de fsh que comprenden alcohol bencilico como agente preservativo.Info
- Publication number
- ES2183486T3 ES2183486T3 ES99305664T ES99305664T ES2183486T3 ES 2183486 T3 ES2183486 T3 ES 2183486T3 ES 99305664 T ES99305664 T ES 99305664T ES 99305664 T ES99305664 T ES 99305664T ES 2183486 T3 ES2183486 T3 ES 2183486T3
- Authority
- ES
- Spain
- Prior art keywords
- fsh
- formulations
- variant
- products
- bencilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000003755 preservative agent Substances 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000005755 formation reaction Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003186 pharmaceutical solution Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 238000011285 therapeutic regimen Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere a FSH o a una variante de FSH que contiene una subunidad alfa y beta contenida en formaulaciones, y artículos de fabricación. La invención se refiere a nuevas proteínas ventajosas y ácidos nucleicos, soluciones farmacéuticas multiuso y formulaciones y productos de dichas proteínas y ácidos nucleicos donde ninguno de estos tenían previamente un uso comercial con tales indicaciones de usos extendidas. Estos productos son particularmente útiles en regímenes terapéuticos para aumentar los niveles de suero de FSH o de una variante de FSH durante un periodo de tratamiento. Así, entre otros, la invención cumple con la necesidad de productos convenientes de FSH o de una variante de FSH:
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9390698P | 1998-07-23 | 1998-07-23 | |
| US9461198P | 1998-07-30 | 1998-07-30 | |
| US9476798P | 1998-07-31 | 1998-07-31 | |
| US9871198P | 1998-09-01 | 1998-09-01 | |
| US10069698P | 1998-09-17 | 1998-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2183486T3 true ES2183486T3 (es) | 2003-03-16 |
Family
ID=27536687
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99305664T Expired - Lifetime ES2183486T3 (es) | 1998-07-23 | 1999-07-16 | Formulaciones de fsh y de variantes de fsh que comprenden alcohol bencilico como agente preservativo. |
| ES01130213T Expired - Lifetime ES2250290T3 (es) | 1998-07-23 | 1999-07-16 | Formulaciones estables de fsh y variantes de fsh. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES01130213T Expired - Lifetime ES2250290T3 (es) | 1998-07-23 | 1999-07-16 | Formulaciones estables de fsh y variantes de fsh. |
Country Status (23)
| Country | Link |
|---|---|
| EP (2) | EP1188444B1 (es) |
| JP (1) | JP4719357B2 (es) |
| KR (1) | KR20010083126A (es) |
| CN (1) | CN1309567A (es) |
| AR (1) | AR020618A1 (es) |
| AT (2) | ATE308990T1 (es) |
| AU (1) | AU776823B2 (es) |
| BR (1) | BR9912243A (es) |
| CA (1) | CA2335340C (es) |
| CO (1) | CO5090905A1 (es) |
| DE (2) | DE69928296T2 (es) |
| DK (1) | DK0974359T4 (es) |
| ES (2) | ES2183486T3 (es) |
| ID (1) | ID28747A (es) |
| IL (1) | IL140984A0 (es) |
| MY (1) | MY135913A (es) |
| NO (1) | NO20010326L (es) |
| NZ (1) | NZ508874A (es) |
| PE (1) | PE20000939A1 (es) |
| PL (1) | PL346127A1 (es) |
| PT (1) | PT974359E (es) |
| SI (1) | SI0974359T1 (es) |
| WO (1) | WO2000004913A1 (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6414123B1 (en) * | 1997-10-21 | 2002-07-02 | Vitro Diagnostics, Inc. | Method for purifying FSH |
| US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
| AU779869B2 (en) | 1999-04-13 | 2005-02-17 | Nektar Therapeutics | Pulmonary administration of dry powder formulations for treating infertility |
| TWI318100B (en) | 2001-03-01 | 2009-12-11 | Lonza Ag | Preservative blends containing quaternary ammonium compounds |
| ES2358330T5 (es) * | 2003-04-02 | 2018-12-03 | Ares Trading S.A. | Formulaciones farmacéuticas líquidas de FSH y LH junto con un tensioactivo no iónico |
| WO2004087213A1 (en) * | 2003-04-02 | 2004-10-14 | Ares Trading S.A. | Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| WO2004112826A1 (en) | 2003-06-20 | 2004-12-29 | Ares Trading Sa | Freeze-dried fsh / lh formulations |
| KR101105871B1 (ko) * | 2005-09-27 | 2012-01-16 | 주식회사 엘지생명과학 | 인 난포자극호르몬의 안정한 용액 제형 |
| CA2685437C (en) * | 2007-02-08 | 2015-06-02 | Aspenbio Pharma, Inc. | Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| CN101720332B (zh) | 2007-06-28 | 2014-08-13 | 拉蒂奥法姆有限责任公司 | 生产促卵泡激素的细胞克隆 |
| ES2393233T3 (es) * | 2007-11-01 | 2012-12-19 | Merck Serono S.A. | Formulaciones de LH líquidas |
| RS52106B (sr) * | 2008-02-08 | 2012-08-31 | Biogenerix Ag | Tečni preparat fsh |
| CN102309745B (zh) * | 2008-09-17 | 2013-05-08 | 上海天伟生物制药有限公司 | 一种卵泡刺激素冻干针剂 |
| ES2558768T3 (es) | 2009-06-24 | 2016-02-08 | Tecpharma Licensing Ag | Dispositivo de administración con función de cebado |
| EP2325194A1 (en) | 2009-11-24 | 2011-05-25 | Glycotope GmbH | Process for the purification of glycoproteins |
| WO2011076281A1 (de) | 2009-12-23 | 2011-06-30 | Tecpharma Licensing Ag | Entfernen einer nadelschutzkappe von einer nadel |
| EP2515973B1 (de) | 2009-12-23 | 2018-02-21 | Tecpharma Licensing AG | Injektionsvorrichtung mit einer nadelschutzhülse |
| US8684744B2 (en) | 2010-02-11 | 2014-04-01 | Finox Ag | Injection training dummy |
| RU2553375C2 (ru) * | 2010-02-12 | 2015-06-10 | Интас Биофармасьютикалс Лимитед | Жидкий состав фолликулостимулирующего гормона |
| EP2417982A1 (en) | 2010-07-30 | 2012-02-15 | Ferring B.V. | Stabilization of gonadotropins |
| KR20140018970A (ko) * | 2011-04-22 | 2014-02-13 | 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 | 저수준 잔류용매를 함유한 당단백질 조성물 및 그 제조방법과 용도 |
| JP5750471B2 (ja) * | 2013-05-22 | 2015-07-22 | Jcrファーマ株式会社 | 組換え体ヒトfshの製造方法 |
| CN103539860B (zh) * | 2013-11-01 | 2014-12-03 | 广州优联康医药科技有限公司 | 一种长效重组人促卵泡激素融合蛋白 |
| CN103554269B (zh) * | 2013-11-01 | 2015-02-11 | 广州联康生物科技有限公司 | 重组猪促卵泡激素融合蛋白 |
| CN103539861B (zh) * | 2013-11-01 | 2015-02-18 | 广州联康生物科技有限公司 | 长效重组人促卵泡激素融合蛋白 |
| HK1223559A1 (zh) * | 2013-11-12 | 2017-08-04 | Cadila Healthcare Limited | 用於促性腺激素的配方 |
| BR112018003455A2 (pt) * | 2015-09-17 | 2018-09-25 | Glycotope Gmbh | composição ou composição farmacêutica e uso da composição |
| GB201603280D0 (en) | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB839300A (en) * | 1957-09-05 | 1960-06-29 | Organon Labor Ltd | Adrenocorticotropic hormone preparations and process for making same |
| US4659696A (en) † | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
| US5162306A (en) * | 1987-01-23 | 1992-11-10 | Donaldson Lloyd E | Composition and method for producing superovulation in mammals |
| IT1206302B (it) * | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
| FR2623715B1 (fr) * | 1987-11-26 | 1990-12-21 | Lafon Labor | Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite |
| US5733572A (en) * | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| DK0955062T3 (da) * | 1992-07-31 | 2007-09-17 | Genentech Inc | Vandig formulering indeholdende humant væksthormon |
| US5661125A (en) * | 1992-08-06 | 1997-08-26 | Amgen, Inc. | Stable and preserved erythropoietin compositions |
| ATE178789T1 (de) † | 1994-02-21 | 1999-04-15 | Takeda Chemical Industries Ltd | Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe |
| TW426523B (en) * | 1995-04-06 | 2001-03-21 | Hoffmann La Roche | Interferon solution |
| JP4057058B2 (ja) * | 1995-11-07 | 2008-03-05 | ジェネンテック インコーポレーテッド | Ngfの安定化処方 |
| GB2317010A (en) * | 1996-09-04 | 1998-03-11 | Eev Ltd | Gas sensor detecting only non-reflected light |
| TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
| US6287587B2 (en) † | 1997-07-15 | 2001-09-11 | Takeda Chemical Industries, Ltd. | Process for producing sustained-release preparation by in-water drying |
| MY120063A (en) * | 1997-12-09 | 2005-08-30 | Lilly Co Eli | Stabilized teriparatide solutions |
| JP2000151148A (ja) * | 1998-11-13 | 2000-05-30 | Mitsumi Electric Co Ltd | 携帯用電子機器のコード接続構造 |
-
1999
- 1999-07-15 CA CA2335340A patent/CA2335340C/en not_active Expired - Lifetime
- 1999-07-15 ID IDW20010141A patent/ID28747A/id unknown
- 1999-07-15 PL PL99346127A patent/PL346127A1/xx not_active Application Discontinuation
- 1999-07-15 JP JP2000560906A patent/JP4719357B2/ja not_active Expired - Lifetime
- 1999-07-15 IL IL14098499A patent/IL140984A0/xx unknown
- 1999-07-15 WO PCT/US1999/016031 patent/WO2000004913A1/en not_active Ceased
- 1999-07-15 KR KR1020017000781A patent/KR20010083126A/ko not_active Ceased
- 1999-07-15 NZ NZ508874A patent/NZ508874A/xx unknown
- 1999-07-15 BR BR9912243-0A patent/BR9912243A/pt not_active IP Right Cessation
- 1999-07-15 CN CN99808813A patent/CN1309567A/zh active Pending
- 1999-07-15 AU AU49980/99A patent/AU776823B2/en not_active Expired
- 1999-07-16 DE DE69928296T patent/DE69928296T2/de not_active Expired - Lifetime
- 1999-07-16 AT AT01130213T patent/ATE308990T1/de active
- 1999-07-16 ES ES99305664T patent/ES2183486T3/es not_active Expired - Lifetime
- 1999-07-16 EP EP01130213A patent/EP1188444B1/en not_active Revoked
- 1999-07-16 EP EP99305664A patent/EP0974359B2/en not_active Expired - Lifetime
- 1999-07-16 DE DE69904262T patent/DE69904262T3/de not_active Expired - Lifetime
- 1999-07-16 PT PT99305664T patent/PT974359E/pt unknown
- 1999-07-16 AT AT99305664T patent/ATE228850T1/de active
- 1999-07-16 SI SI9930156T patent/SI0974359T1/xx unknown
- 1999-07-16 DK DK99305664T patent/DK0974359T4/da active
- 1999-07-16 ES ES01130213T patent/ES2250290T3/es not_active Expired - Lifetime
- 1999-07-21 CO CO99045916A patent/CO5090905A1/es unknown
- 1999-07-22 MY MYPI99003089A patent/MY135913A/en unknown
- 1999-07-22 PE PE1999000738A patent/PE20000939A1/es not_active Application Discontinuation
- 1999-07-22 AR ARP990103624A patent/AR020618A1/es not_active Application Discontinuation
-
2001
- 2001-01-19 NO NO20010326A patent/NO20010326L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135913A (en) | Fsh and fsh variant formulations comprising benzyl alcohol as a preservative | |
| ES2173978T3 (es) | Utilizacion de un alcohol graso insaturado. | |
| AR018526A1 (es) | COMPOSICION FARMACEUTICA NO LIOFILIZADA EN FORMA DE SOLUCIoN QUE COMPRENDE LA HORMONA PARATIROIDEA HUMANA, PROCESO PARA PREPARA UN FRASCO O CARTUCHO QUE LA CONTIENE, PROCESO PARA PREPARAR DICHA COMPOSICIoN, FRASCO O CARTUCHO QUE CONTIENE LA COMPOSICIoN Y USO DE LA MISMA PARA LA FABRICACIoN DE UN MED | |
| ES2040727T3 (es) | Un proceso para preparar una formulacion en aerosol en solucion de un analogo. | |
| ES2068791T1 (es) | Metodos y acido desoxirribonucleico para la preparacion de proteina de factor de tejido. | |
| ES2057124T3 (es) | Producto terapeutico para el tratamiento de estados peri- o post-menopausicos. | |
| FI962799A0 (fi) | Nukleiinihappoja sisältävä valmiste, sen valmistus ja käyttö | |
| ES2171971T3 (es) | Producto limpiador y de tratamiento con almidon. | |
| AR092919A2 (es) | Composicion farmaceutica liquida | |
| ES2194935T3 (es) | Preparados estables de transglutaminasa y procedimiento para su preparacion. | |
| ES2045386T3 (es) | Preparados orales. | |
| ES2012362B3 (es) | Agente cosmetico del cabello | |
| IT8224915A0 (it) | Uso di peptidi come medicamenti. | |
| CO5160321A1 (es) | Novedosas composiciones de tipranavir y ritonavir | |
| ES2177594T3 (es) | Combinaciones de sustancias y asoactivas con acidos grasos para prevenir la caida del cabello. | |
| DE19475001I2 (de) | Anthelminthische Wirkstoffkombinationen. | |
| ES2104133T3 (es) | Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico. | |
| ES2045768T3 (es) | Composiciones topicas que contienen defibrotida. | |
| ES2061521T3 (es) | Proteinas con actividad glutation-s-transferasa, secuencias de adn, anticuerpos, poxvirus y medicamentos para la prevencion de la equistosomiasis. | |
| ES2180729T3 (es) | Tratamiento terapeutico combinado de las patologias hiperproliferantes. | |
| SV1998000040A (es) | Composiciones farmaceuticas ref. pu3210/sv | |
| ATE129146T1 (de) | Stiftzusammensetzung enthaltend salzsäurenatrium und stearylalkohol. | |
| IL67925A0 (en) | Laevorotatory isomer of mequitazine,its preparation and pharmaceutical compositions containing it | |
| FI821324A0 (fi) | Oxazolderivat | |
| DK52080A (da) | Dehydropeptider fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler |